Aqualung Therapeutics Receives $1.7 Million NIH Fastrack Award

Cardiovascular Default News Photo Image

Aqualung Therapeutics Corporation founder and CEO Dr. Joe "Skip" Garcia, a BIO5 Faculty Member and UA COM-T Professor of Internal Medicine, Medicine, Pharmacology & Toxicology, Physiological Sciences, and Physiology, received the National Institute of Health Fastrack Award to develop a novel immune-based therapeutic antibody for critically ill patients with an acute lung injury.